pbgene-dmd
pbgene-dmd: developed by 1 company · 1 clinical trial tracked · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase 1/2a, Multi-center, Open-label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of PBGENE-DMD in Participants With Duchenne Muscular Dystrophy (FUNCTION-DMD)
FDA Decisions
FDA_MeetingFDA cleared the IND application for the PBGENE-DMD program, allowing the FUNCTION-DMD Phase 1/2 clinical study to proceed.(DTIL)
Frequently asked questions
Who is developing pbgene-dmd?
pbgene-dmd is being developed by PRECISION BIOSCIENCES INC.
How many clinical trials involve pbgene-dmd?
BioSniper tracks 1 clinical trial involving pbgene-dmd.
What is pbgene-dmd's latest FDA decision?
The most recent tracked FDA decision for pbgene-dmd is FDA_Meeting for FDA cleared the IND application for the PBGENE-DMD program, allowing the FUNCTION-DMD Phase 1/2 clinical study to proceed., dated February 11, 2026.
Get deeper analysis on pbgene-dmd
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis